Clinical Trial Update: Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of radiation therapy, temozolomide, tamoxifen, and carboplatin for malignant gliomas; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Glioma

Drugs mentioned

• Nolvadex (tamoxifen)
• Paraplatin (Carboplatin)
• Temodar (Temozolomide)

Snippet

Sponsor: San Diego Pacific Oncology & Hematology Associates | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: UNKNOWN